Skip to main
MMSI

MMSI Stock Forecast & Price Target

MMSI Analyst Ratings

Based on 8 analyst ratings
Buy
Strong Buy 38%
Buy 38%
Hold 25%
Sell 0%
Strong Sell 0%

Bulls say

Merit Medical Systems is well-positioned for continued organic growth with a strong track record of successfully executing on previous plans. The company's new Long-Range Plan is expected to be unveiled later this year and is likely to include a combination of both gross margin expansion through various initiatives and SG&A leverage. With a solid financial position, MMSI also has the ability to pursue tuck-in acquisitions for continued growth opportunities.

Bears say

Merit Medical Systems is facing challenges in their organic revenue growth, with a slowdown to 3.7% year-over-year in the first quarter of 2026 and a lower projected growth rate for the rest of the year. The company's gross margin was also negatively impacted by tariffs, and its operating margin improved only slightly. Additionally, while the company has maintained strong free cash flow and a solid balance sheet, there are concerns about their reliance on external growth and the potential for unsuccessful new product launches.

MMSI has been analyzed by 8 analysts, with a consensus rating of Buy. 38% of analysts recommend a Strong Buy, 38% recommend Buy, 25% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Merit Medical Systems and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Merit Medical Systems (MMSI) Forecast

Analysts have given MMSI a Buy based on their latest research and market trends.

According to 8 analysts, MMSI has a Buy consensus rating as of Sep 28, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $98.50, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $98.50, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Merit Medical Systems (MMSI)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.